Contraceptives: a look at the future.
Monier
M
M
University of Arizona, Tucson.
Laird
M
M
D000019:Abortifacient Agents; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female / Q000008:administration & dosage; D003272:Contraceptive Agents, Male; D003274:Contraceptive Devices, Female / Q000639:trends*; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage; D003692:Delayed-Action Preparations; D004343:Drug Implants; D005260:Female; D005544:Forecasting; D006801:Humans; D007267:Injections; D016912:Levonorgestrel; D008297:Male; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000031:analogs & derivatives; D017258:Medroxyprogesterone Acetate; D009644:Norgestrel / Q000008:administration & dosage; D011247:Pregnancy
D000019:Abortifacient Agents; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003272:Contraceptive Agents, Male; D003277:Contraceptives, Oral, Combined; D003692:Delayed-Action Preparations; D004343:Drug Implants; D009644:Norgestrel; D016912:Levonorgestrel; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone